STAT |
Advances in gene editing, and hype, underlie Editas move to go public
STAT Advances in gene editing, and hype, underlie Editas move to go public. By Sharon Begley. January 5, 2016. Katherine Taylor for STAT. Dr. Feng Zhang, a cofounder of Editas Medicine, made some of the key genome-editing discoveries the company hopes to ... |
donderdag 7 januari 2016
Advances in gene editing, and hype, underlie Editas move to go public - STAT
